Your browser doesn't support javascript.
loading
Side effects of 1% cyclopentolate hydrochloride in children and adolescents attended at Centro Universitário FMABC
Valentino, Ianna Luiza Avelino; Fernandez, Celso Lopez; Fonseca, Fernando Luiz Affonso; Veiga, Glaucia Luciano da; Lima, Vagner Loduca.
  • Valentino, Ianna Luiza Avelino; Centro Universitário FMABC. Discipline of Ophthalmology. Santo André. BR
  • Fernandez, Celso Lopez; Centro Universitário FMABC. Discipline of Ophthalmology. Santo André. BR
  • Fonseca, Fernando Luiz Affonso; Universidade Federal de São Paulo. Department of Pharmaceutical Sciences. Diadema. BR
  • Veiga, Glaucia Luciano da; Centro Universitário FMABC. Discipline of Ophthalmology. Santo André. BR
  • Lima, Vagner Loduca; Centro Universitário FMABC. Discipline of Ophthalmology. Santo André. BR
ABCS health sci ; 45(Supl. 3): e020106, 10 June 2020. tab, graf
Article in English | LILACS | ID: biblio-1252378
ABSTRACT

INTRODUCTION:

It is known that vision disorders are within the context of public health problems. In childhood, during the neuropsychomotor development phase, visual changes are crucial, since there is a strong correlation between poor school performance and changes in acuity. For these reasons, ophthalmological examination in children, including refraction, is extremely important, aiming at the early diagnosis of diseases and possible refractive errors that may compromise the child's life and development. 1% cyclopentolate hydrochloride eye drops are the most used during ophthalmic clinical evaluation as a cycloplegic and mydriatic agent to assist in refractive examination.

OBJECTIVE:

The ocular and systemic side effects of 1% cyclopentolate hydrochloride eye drops were studied in patients who underwent static refractive examination in the strabismus sector of the Ophthalmology Discipline of the Centro Universitário FMABC.

METHODS:

A drop of 1% cyclopentolate is instilled in both eyes of each patient and the possible ocular and systemic signs and symptoms presented were observed after 40 minutes and 24 hours after instillation.

RESULTS:

We expect to find ocular side effects more evident than systemic symptoms in the two evaluation times (40 minutes and 24 hours after instillation). All symptoms (ocular and systemic) are reversed spontaneously.

CONCLUSION:

The present study aims to show that the side effects observed by the topical (ocular) use of cyclopentolate eye drops 1% are few and present spontaneous reversal both from an eye point of view, as well as from a systemic point of view.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Ophthalmic Solutions / Refraction, Ocular / Child Health / Cyclopentolate / Adolescent Health / Eye Health Services Type of study: Observational study / Screening study Limits: Adolescent / Child / Female / Humans / Male Language: English Journal: ABCS health sci Journal subject: Medicine / Public Health Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Centro Universitário FMABC/BR / Universidade Federal de São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Ophthalmic Solutions / Refraction, Ocular / Child Health / Cyclopentolate / Adolescent Health / Eye Health Services Type of study: Observational study / Screening study Limits: Adolescent / Child / Female / Humans / Male Language: English Journal: ABCS health sci Journal subject: Medicine / Public Health Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Centro Universitário FMABC/BR / Universidade Federal de São Paulo/BR